PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Successful Completion of Entitlement Offer, page-3

  1. 1,416 Posts.
    lightbulb Created with Sketch. 276
    maybe because all shares rank equally. The retail component was good for retail as as it turned out it gave them an opportunity to buy as much as they wanted at same price as instos.
    thinking about it the other way, had there not been a fully underwritten $20m retail offer then i dont believe the price would have gone as low as circa 125c. I believe the instos were keen to get their underwritten shares also so what better way than to keep price at or around offer price.
    i think the outcome was a win/win/win. Par got their money. Instos got their underwritten shares and retail could fill their boots at insto offer price. Everyone got a chance to achieve their desired outcomes if they took action



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.